Pancreatic Cancer Research

ResearcherZhejiang Provincial People's HospitalActive in the last 2 years

Ran Tao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0237-4623; OpenAlex author ID A5101448566. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
5
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 3

  1. TSPAN15 sustains ITGB1 stability to block gemcitabine-induced ferroptosis in pancreatic ductal adenocarcinoma through the FAK/AKT/Mtor-gpx4 cascade. Last author DOI 10.1016/j.redox.2025.103721↗
  2. Advances of immune-checkpoint inhibition of CTLA-4 in pancreatic cancer. Last author DOI 10.1016/j.biopha.2024.117430↗
  3. An Update on Gemcitabine-Based Chemosensitization Strategies in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.31083/j.fbl2812361↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ran Ni · 2 shared papers, 2023–2024 · strength 0.58
  2. Zongting Gu · 2 shared papers, 2023–2025 · strength 0.50
  3. Xiao Wang · 1 shared paper, 2025 · strength 0.28
  4. Peng Nan · 1 shared paper, 2025 · strength 0.28
  5. Tianpeng Zhang · 1 shared paper, 2023 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.